{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T17:33:40Z","timestamp":1772645620038,"version":"3.50.1"},"reference-count":16,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia\/Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior"},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bioengineering"],"abstract":"<jats:p>Ovarian cancer progression is strongly influenced by tumour hypoxia and associated oxidative stress. Experimental evidence indicates that cysteine availability supports ovarian cancer cell fitness under hypoxic conditions, yet the quantitative integration of cysteine metabolism, redox control, and energetic maintenance remains incompletely understood. We present a reduced mechanistic mathematical model describing intracellular cysteine allocation between glutathione (GSH) synthesis and hydrogen sulfide production under experimentally imposed hypoxia. The model integrates extracellular cysteine uptake, GSH-dependent reactive oxygen species (ROS) detoxification, hypoxia-amplified ROS generation, and redox-modulated ATP maintenance. Parameter estimation was performed using experimentally derived extracellular metabolite fluxes measured over a 24 h interval. Uncertainty was assessed via bootstrap resampling, and variance-based sensitivity analysis was conducted within (patho)physiologically constrained parameter domains. The calibrated model reproduces extracellular fluxes with relative deviations below 7% and identifies GSH synthesis capacity as the dominant determinant of ATP maintenance within experimentally supported ranges. Hydrogen sulfide (H2S) production exerts a secondary stabilising influence, whereas hypoxia-driven ROS amplification negatively impacts energetic state. Numerical continuation across hypoxia levels reveals distinct qualitative response regions but does not imply a formal bifurcation structure. Importantly, intracellular metabolite dynamics are inferred as latent variables consistent with extracellular constraints and established biochemical knowledge; the model does not uniquely identify intracellular pool sizes or enzyme kinetics. The framework therefore provides flux-consistent mechanistic plausibility rather than direct intracellular validation. This systems-level analysis supports cysteine allocation as a quantitatively influential control point in hypoxic adaptation and establishes a constrained modelling framework for subsequent metabolic network expansions and experimental validation.<\/jats:p>","DOI":"10.3390\/bioengineering13030300","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T13:11:36Z","timestamp":1772629896000},"page":"300","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Mathematical Model of Cysteine-Driven Metabolic Adaptation to Hypoxia in Ovarian Cancer"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5630-7149","authenticated-orcid":false,"given":"Jos\u00e9 A.","family":"Rodrigues","sequence":"first","affiliation":[{"name":"CIMA and Department of Mathematics of Instituto Superior de Engenharia de Lisboa\u2013ISEL, Polytechnic University of Lisbon, Rua Conselheiro Em\u00eddio Navarro, 1, 1959-007 Lisbon, Portugal"},{"name":"CIMOSM, ISEL\u2014Centro de Investiga\u00e7\u00e3o em Modela\u00e7\u00e3o e Optimiza\u00e7\u00e3o de Sistemas Multifuncionais, Instituto Superior de Engenharia de Lisboa, 1959-007 Lisboa, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0802-7753","authenticated-orcid":false,"given":"Sofia C.","family":"Nunes","sequence":"additional","affiliation":[{"name":"NOVA Medical School|Faculdade de Ci\u00eancias M\u00e9dicas, Universidade NOVA de Lisboa, Campo dos M\u00e1rtires da P\u00e1tria 130, 1169-056 Lisbon, Portugal"},{"name":"Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil (IPOLFG), Rua Prof. Lima Basto, 1099-023 Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3822-2835","authenticated-orcid":false,"given":"Cristiano","family":"Ramos","sequence":"additional","affiliation":[{"name":"NOVA Medical School|Faculdade de Ci\u00eancias M\u00e9dicas, Universidade NOVA de Lisboa, Campo dos M\u00e1rtires da P\u00e1tria 130, 1169-056 Lisbon, Portugal"},{"name":"Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil (IPOLFG), Rua Prof. Lima Basto, 1099-023 Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5683-3552","authenticated-orcid":false,"given":"Luis G.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[{"name":"Instituto de Tecnologia Qu\u00edmica e Biol\u00f3gica Ant\u00f3nio Xavier (ITQB NOVA), Avenida da Rep\u00fablica (EAN), 2780-157 Oeiras, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1548-5907","authenticated-orcid":false,"given":"Jacinta","family":"Serpa","sequence":"additional","affiliation":[{"name":"NOVA Medical School|Faculdade de Ci\u00eancias M\u00e9dicas, Universidade NOVA de Lisboa, Campo dos M\u00e1rtires da P\u00e1tria 130, 1169-056 Lisbon, Portugal"},{"name":"Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil (IPOLFG), Rua Prof. Lima Basto, 1099-023 Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jama.2025.9495","article-title":"Ovarian cancer: A review","volume":"334","author":"Caruso","year":"2025","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","article-title":"Hypoxia in cancer: Significance and impact on clinical outcome","volume":"26","author":"Vaupel","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"ref_4","first-page":"9","article-title":"Role of oxidative stress in epithelial ovarian cancer in Egyptian patients","volume":"12","author":"Ramadan","year":"2017","journal-title":"J. Exp. Ther. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41416-020-01156-1","article-title":"Cysteine metabolic circuitries: Druggable targets in cancer","volume":"124","author":"Pereira","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"9513","DOI":"10.1038\/s41598-018-27753-y","article-title":"Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity","volume":"8","author":"Nunes","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Nunes, S.C., Ramos, C., Santos, I., Mendes, C., Silva, F., Vicente, J.B., Pereira, S.A., F\u00e9lix, A., Gon\u00e7alves, L.G., and Serpa, J. (2021). Cysteine boosts fitness under hypoxia-mimicked conditions in ovarian cancer by metabolic reprogramming. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.722412"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"21699","DOI":"10.1038\/s41598-022-26205-y","article-title":"Hypoxia, acidification and oxidative stress in cells cultured at large distances from an oxygen source","volume":"12","author":"Hochmann","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1158\/0008-5472.CAN-18-2616","article-title":"Collagen remodeling in the hypoxic tumor-mesothelial niche promotes ovarian cancer metastasis","volume":"79","author":"Natarajan","year":"2019","journal-title":"Cancer Res."},{"key":"ref_10","first-page":"1661","article-title":"Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: Its impact on prognosis and on response to chemotherapy","volume":"7","author":"Birner","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ijc.28699","article-title":"Knockdown of Nrf2 suppresses glioblastoma angiogenesis by inhibiting hypoxia-induced activation of HIF-1\u03b1","volume":"135","author":"Ji","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Manfreda, L., Rruga, F., Zanolli, A., Marzullo, B., Vettore, L., Canton, M., Marchioro, C., Rampazzo, E., Mariotto, E., and Tennant, D.A. (2025). Nrf2 Activation is Required for Chemotherapy Resistance Acquisition in Medulloblastoma Via Metabolic and Redox Adaptation. SSRN, preprint.","DOI":"10.2139\/ssrn.5186264"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cpt.2025.07.003","article-title":"Investigating hypoxia-inducible factor signaling in cancer: Mechanisms, clinical implications, targeted therapeutic strategies, and resistance","volume":"4","author":"Shaikat","year":"2026","journal-title":"Cancer Pathog. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Szabo, C. (2021). Hydrogen Sulfide, an Endogenous Stimulator of Mitochondrial Function in Cancer Cells. Cells, 10.","DOI":"10.3390\/cells10020220"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41420-024-01868-w","article-title":"The potential role of hydrogen sulfide in cancer cell apoptosis","volume":"10","author":"Gao","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Nunes, S.C., Lopes-Coelho, F., Gouveia-Fernandes, S., Ramos, C., Pereira, S.A., and Serpa, J. (2018). Cysteine boosts the evolutionary adaptation to CoCl2 mimicked hypoxia conditions, favouring carboplatin resistance in ovarian cancer. BMC Evol. Biol., 18.","DOI":"10.1186\/s12862-018-1214-1"}],"container-title":["Bioengineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-5354\/13\/3\/300\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T13:54:20Z","timestamp":1772632460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-5354\/13\/3\/300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":16,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["bioengineering13030300"],"URL":"https:\/\/doi.org\/10.3390\/bioengineering13030300","relation":{},"ISSN":["2306-5354"],"issn-type":[{"value":"2306-5354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]}}}